| Recruiting | A Phase I Study of Single Subcutaneous Dose of SHR-1894 in Healthy Subjects NCT07414602 | Suzhou Suncadia Biopharmaceuticals Co., Ltd. | Phase 1 |
| Active Not Recruiting | Multicentre Real-life Data Collection Study With CareMin650™ in the Prevention and Treatment of Oral Mucositis NCT07054528 | Centre Hospitalier de Valenciennes | — |
| Recruiting | PMCF Investigation of Medical Device ChitoCare® Medical NCT06850389 | Primex ehf | — |
| Recruiting | Post-Marketing Clinical Follow-Up Trial to Evaluate the Performance and Safety of the Medical Device 047 TD De NCT07056569 | Biokosmes Srl | N/A |
| Active Not Recruiting | ATI-045 Versus Placebo in Patients With Moderate-to-Severe Atopic Dermatitis NCT07011706 | Aclaris Therapeutics, Inc. | Phase 2 |
| Recruiting | HYPNOsis in the Management of Atopic Dermatitis in Children and Teenagers NCT05611346 | Centre Hospitalier Universitaire de la Réunion | N/A |
| Recruiting | Abrocitinib Taiwan Treatment Pattern and Real World Study in ATopiC Dermatitis (ATTRACT Registry) NCT06353087 | Pfizer | — |
| Completed | Using Artificial Intelligence to Help Doctors Identify Different Skin Conditions and Improve Patient Care NCT07428954 | AI Labs Group S.L | — |
| Completed | A Study of the Effects of Camoteskimab in Adults With Moderate to Severe Atopic Dermatitis NCT06436183 | Apollo Therapeutics Ltd | Phase 2 |
| Completed | Prevalence of Skin Sensitization and Dermatitis Among Epoxy-exposed Workers in the Wind Turbine Industry. NCT05891743 | Siemens Gamesa Renewable Energy Blades, S.A. | — |
| Completed | Impact of Combining Incontinence-associated Dermatitis Prevention and Management Course and Directive Wheel Ch NCT06835192 | Kaohsiung Medical University Chung-Ho Memorial Hospital | N/A |
| Completed | Use of Low-level Laser Therapy in the Treatment of Incontinence-associated Dermatitis in the Elderly NCT05699122 | Hospital Israelita Albert Einstein | N/A |
| Withdrawn | Treatment of Chronic Itch in Atopic Dermatitis With Opioid Antagonist Naltrexone NCT04325802 | University of Minnesota | Phase 2 |
| Completed | Tacrolimus Versus Hydrocortisone in Atopic Dermatitis NCT05324618 | Ain Shams University | Phase 4 |
| Completed | Clinical Investigation on the Efficacy and Safety of Relizema Ecofoam NCT05001139 | Relife S.r.l. | N/A |
| Completed | ECP for Immune-related Adverse Events After Checkpoint Inhibitor Treatment NCT05414552 | University of Freiburg | — |
| Completed | Clinical Investigation on the Performance and Safety of DermoRelizema Ecofoam NCT04826471 | Relife S.r.l. | N/A |
| Completed | Study on Hypoallergenic Hair Dye NCT04772482 | University of Minnesota | — |
| Completed | A Study of Lebrikizumab (LY3650150) in Combination With Topical Corticosteroids in Japanese Participants With NCT04760314 | Eli Lilly and Company | Phase 3 |
| Completed | Implementation of a Minor Ailment Service in Community Pharmacy Practice NCT05247333 | Universidad de Granada | N/A |
| Withdrawn | Treatment of Chronic Itch in Atopic Dermatitis With Topical Naltrexone NCT04154033 | University of Minnesota | Phase 2 |
| Completed | Effects on the Scalp Microbiota of a 1% Selenium Disulfide and 1% Salicylic Acid Shampoo After 2% Ketaconazole NCT04057950 | L'Oreal | N/A |
| Completed | A Study to Evaluate Risankizumab in Adults and Adolescents With Moderate to Severe Atopic Dermatitis NCT03706040 | AbbVie | Phase 2 |
| Completed | Study Evaluating Efficacy and Safety of PF-04965842 and Dupilumab in Adult Subjects With Moderate to Severe At NCT03720470 | Pfizer | Phase 3 |
| Completed | Effect of Benralizumab in Atopic Dermatitis NCT03563066 | McMaster University | Phase 2 |
| Completed | Study to Investigate Efficacy and Safety of PF-04965842 in Subjects Aged 12 Years and Over With Moderate to Se NCT03627767 | Pfizer | Phase 3 |
| Completed | Human Repeated Insult Patch Test NCT03474874 | NeXtGen Biologics, Inc. | N/A |
| Unknown | Interest of Photographs by Smartphone in Dermatology NCT03493724 | Central Hospital, Nancy, France | — |
| Completed | Micro-Technique Sampling NCT03242577 | Kimberly-Clark Corporation | — |
| Unknown | Maintaining Lower Levels of Care Through Automated Perineal Hygiene NCT03051321 | SchwabCare | N/A |
| Unknown | Treatment of Incontinence Associated Dermatitis - Automated NCT03046810 | SchwabCare | N/A |
| Completed | Rudolph: Nasal Microbiota With Red and Sore Nose NCT03073837 | Kimberly-Clark Corporation | N/A |
| Recruiting | Epicutaneous Testing of Cosmetics for Skin Compatibility NCT03024671 | Insel Gruppe AG, University Hospital Bern | N/A |
| Completed | Infant Fecal Insult Study NCT02979210 | Kimberly-Clark Corporation | N/A |
| Completed | A Study Comparing the Quality of Life of Patients in the Treatment of Eczema by Pediatric Generalists and Spec NCT02916888 | Yale University | — |
| Unknown | ALDH2 Mutation in Taiwanese Head and Neck Cancer NCT02761408 | Taipei Veterans General Hospital, Taiwan | — |
| Completed | A Single-Center, Exploratory Study to Analyze the Dynamics of Skin Microflora Following Exposure to Surfactant NCT02615912 | Kimberly-Clark Corporation | N/A |
| Completed | Non Interventional Clinical Investigation of Ectoin Ear Spray in Skin Treatment of Outer Ear Canal Irritations NCT02558738 | Bitop AG | — |
| Unknown | Study of Epigallocatechin-3-gallate (EGCG) for Skin Prevention in Patients With Breast Cancer Receiving Adjuva NCT02580279 | Shandong Cancer Hospital and Institute | Phase 2 |
| Completed | A Clinical Evaluation of 3M Cavilon Advanced Barrier Film for the Treatment of Incontinence Associated Dermati NCT02724449 | Solventum US LLC | N/A |
| Completed | ADRN Barrier/Immunoprofiling Exploratory Pilot Study NCT02115399 | National Institute of Allergy and Infectious Diseases (NIAID) | — |
| Completed | Efficacy and Safety Study of Desloratadine (MK-4117) in Japanese Participants With Eczema/Dermatitis and Derma NCT01916980 | Organon and Co | Phase 3 |
| Unknown | Evaluation of Irritancy/Allergic Sensitivity to Natural Personal-care Products by Patch Tests NCT01816542 | Mother's Choice Ltd | N/A |
| Completed | A Confirmatory Study of TAU-284 in Pediatric Patients With Atopic Dermatitis NCT01840605 | Tanabe Pharma Corporation | Phase 3 |
| Completed | Characterisation of T-cell Response to Keyhole Limpet Hemocyanin (KLH) and Tuberculin Purified Protein Derivat NCT01910662 | GlaxoSmithKline | Phase 1 |
| Completed | Barrier Film vs. Standard Skin Care in Preventing Dermatitis in Women With Breast Cancer Receiving Radiation NCT01762020 | London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's | Phase 3 |
| Recruiting | Effects of Treatments on Atopic Dermatitis NCT01631617 | National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) | Phase 2 |
| Unknown | Randomized Study for Effectiveness and Safety Evaluation of Dexamethasone 0.5 mg + Fumarate Clemastine 1 mg Co NCT01239719 | Azidus Brasil | Phase 3 |
| Completed | Sequential Ascending Dose Study to Assess the Safety and Tolerability of REGN668 (SAR231893) in Patients With NCT01259323 | Regeneron Pharmaceuticals | Phase 1 |
| Withdrawn | Efficacy and Safety of the Association Drugs in Patients With Allergic Dermatitis NCT01125761 | Azidus Brasil | Phase 3 |
| Unknown | A Randomised Clinical Trial in a Population of Health Care Workers With Hand Eczema NCT01012453 | Zealand University Hospital | N/A |
| Completed | Topical Application of Sulforaphane-containing Broccoli Sprout Extracts on Radiation Dermatitis NCT00894712 | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | — |
| Completed | Killer Immunoglobulin-Like Receptor Transcripts Expression for the Diagnosis of Epidermotropic Cutaneous T Cel NCT00748319 | Assistance Publique - Hôpitaux de Paris | N/A |
| Completed | Evaluating for Contact Allergies in Patients With Chronic Urticaria NCT00868036 | Tufts Medical Center | — |
| Withdrawn | A Placebo Controlled 4 Week Proof of Concept Study With 0.5% Roflumilast Cream in Patients With Mild Atopic De NCT00746382 | AstraZeneca | Phase 2 |
| Completed | Phase 1 Study of Levocetirizine NCT02447393 | GlaxoSmithKline | Phase 1 |
| Completed | Salmon in Pregnancy Study NCT00801502 | University Hospital Southampton NHS Foundation Trust | N/A |
| Unknown | Olive Oil With Omega 3 to Treat Stasis Dermatitis NCT00421161 | Assaf-Harofeh Medical Center | Phase 1 / Phase 2 |
| Completed | Randomized Phase III Study to Evaluate the Efficacy and Safety of Xyzal® (Levocetirizine) vs Zyrtec® (Cetirizi NCT00375713 | UCB Pharma | Phase 3 |
| Terminated | Study to Compare Different Light Therapies (Narrowband Ultraviolet B vs PUVA) for Hand and Foot Skin Diseases. NCT00217009 | Mayo Clinic | EARLY_Phase 1 |
| Completed | Study of the Safety and Efficacy of Tacrolimus Ointment in Treating Chronic Allergic Contact Dermatitis NCT00667056 | Astellas Pharma Inc | Phase 4 |
| Terminated | Atopic Dermatitis-Like Skin Disease in Pediatric Heart Transplant Patients NCT00176956 | Hordinsky, Maria K., MD | Phase 3 |
| Completed | Assessment of Digital Imaging as a Tool for Diagnosing Psoriasis, Hand Rashes and Unusual Moles NCT00005781 | National Cancer Institute (NCI) | — |
| Completed | Induction of Suction Blisters in Patients With Urticaria, Blistering Diseases, Inflammatory Dermatoses and Neo NCT00001150 | National Cancer Institute (NCI) | — |